News for Healthier Living

GLP-1 RAs Show No Clear Advantage Over DPP4is in Dementia Risk Among Older Adults with Diabetes

A target trial emulation study compared the effect of glucagon-like peptide-1 receptor agonists (GLP-1RAs) versus dipeptidyl peptidase-4 inhibitors (DPP4is) as the second-line therapy for type 2 diabetes on the risk for dementia among older adults.

July 21, 2025


July 26 2025

July 25 2025

July 24 2025

July 23 2025

July 22 2025

July 21 2025

July 20 2025

July 19 2025

July 18 2025

July 17 2025

July 16 2025

July 15 2025

July 14 2025

July 13 2025

July 12 2025